Dr. Stuart Ibsen joined Oregon Health and Science University in 2017 as an associate professor of biomedical engineering in the School of Medicine and a member of CEDAR at the OHSU Knight Cancer Institute. He holds a Ph.D. in zoology from the University of Hawaii, where he studied bioacoustics with a focus on dolphin echolocation, and a second Ph.D. in biomedical engineering from the University of California San Diego, with a focus on drug delivery for chemotherapy applications. His postdoctoral training included positions at the Salk Institute for Biological Studies developing sonogenetics techniques, at the UCSD Moores Cancer Center advancing dielectrophoresis methods for recovering drug delivery vehicles from plasma, at the UCSD Nanoengineering Department working on exosome collection and immunostaining, and at University College London developing therapeutic drug monitoring systems.
Dr. Ibsen’s research focuses on early cancer detection and treatment, light activatable chemotherapy prodrug design, dielectrophoresis-based collection of cancer-derived biomarkers, sonogenetics, and bioacoustics. He has received honors including the NIH Cancer Therapeutics Training Program Fellow Award, Salk Institute Pioneer Fund Postdoctoral Scholar Award, NSF Graduate Research Fellow, and multiple highlighted publications and cover articles. Selected publications include work on rapid isolation and detection of exosomes (ACS Nano, 2017), sonogenetics in C. elegans (Nature Communications, 2015), recovery of drug delivery nanoparticles (Small, 2015), and photoactivatable doxorubicin prodrugs (Pharmaceutical Research, 2010; Photochemistry and Photobiology, 2013). Professional Email: null